Advertisement
The American Medical Association is encouraging clinicians to share their perspectives on electronic heath records and the meaningful use program.

AMA Wants Doctor Input on EHRs, Meaningful Use

0
Doctors encouraged to share stories, e-mail Congress members
For obese individuals

‘Thrifty Phenotype’ Leads to Less Weight Loss in Obese

0
Energy expenditure during fasting and response to overfeeding predict response to caloric restriction
Hippocampal insulin resistance may be a key mediator of cognitive deficits

Hippocampal Insulin Resistance Linked to Neuroplasticity

0
Rat model with hippocampal-specific insulin resistance downregulates insulin receptor expression
An experimental drug

New Drug Effectively Lowers Levels of Triglycerides

0
But it's not yet ready for standard care
The 2015 version of the American Board of Internal Medicine maintenance-of-certification program is expected to generate considerable costs

2015 MOC Program Expected to Cost $5.7 Billion Over 10 Years

0
Time costs account for 90 percent of maintenance of certification costs, estimated at $5.1 billion
The recently developed RAPID score

RAPID Score Validated for Prognosis of Pleural Infections

0
Recently developed score is valid for identifying mortality risk through five years in diverse cohort
For canagliflozin-treated patients with type 2 diabetes

Low Incidence of Diabetic Ketoacidosis With Canagliflozin

0
Canagliflozin-treated patients with type 2 diabetes have low incidence of serious adverse DKA events
The ReShape Integrated Dual Balloon System has been approved by the U.S. Food and Drug Administration to combat adult obesity. Inflated inside the stomach

FDA Approves Balloon Device to Treat Obesity

0
Inflated in stomach, it may create sense of fullness
From 2002 to 2012

Higher Health Costs for Diabetes Mainly Meds, Inpatient Care

0
Individuals with diabetes had more than double the unadjusted mean direct expenditures over 10 years
For Japanese patients who have undergone percutaneous coronary intervention

Atorvastatin/Ezetimibe Beats Atorvastatin After PCI

0
Combination therapy linked to greater coronary plaque regression in Japanese patients